Titles
- Pediatric study plans: content of and process for submitting initial pediatric study plans and amended initial pediatric study plans1
- Pediatric trauma centers: availability, outcomes, and federal support related to pediatric trauma care : report to Congressional requesters1
- Pennsylvania could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- Pennsylvania implemented our prior audit recommendations for critical incidents involving Medicaid enrollees with developmental disabilities but should continue to take action to reduce unreported incidents1
- Peripheral percutaneous transluminal angioplasty (PTA) and specialty catheters: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration staff1
- Peripheral vascular atherectomy devices: premarket notification [510(k)] submissions : guidance for industry and Food and Drug Administration staff2
- Personal firearms: programs that promote safe storage and research on their effectiveness : report to Congressional requesters1
- Pharmacogenomics: a primer for policymakers1
- Pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer: guidance for industry1
- Pharmacy vaccination service availability in nonmetropolitan counties (V3)1
- Physician assessment: measuring competence and performance1
- Physician workforce: caps on Medicare-funded graduate medical education at teaching hospitals : report to Congressional requesters1
- Physician workforce: locations and types of graduate training were largely unchanged, and federal efforts may not be sufficient to meet needs : report to Congressional requesters1
- Physiologically based pharmacokinetic analyses--format and content1
- Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products1
- Policies to achieve near-universal health insurance coverage1
- Policy approaches to reduce what commercial health insurers pay for hospitals’ and physicians’ services1
- Policy approaches to reduce what commercial insurers pay for hospitals’ and physicians’ services1
- Policy clarification for certain fluoroscopic equipment requirements: guidance for industry and Food and Drug Administration staff1
- Policy for certain REMS requirements during the COVID-19 public health emergency: guidance for industry and health care professionals1